1900 1717 
AFP is a type of tumor marker produced by cancer cells or normal cells in response to cancer. High levels of AFP can indicate cancer of the liver, ovaries, or testicles. However, other non-cancerous conditions can also increase AFP levels, so this test alone can't fully diagnose cancer.
198,000 đ
The aPTT is one of several blood coagulation tests. It measures how long it takes your blood to form a clot. When one of your blood vessels is damaged, proteins called clotting factors come together to form clots and quickly stop the bleeding. The aPTT test helps assess how well those clotting factors work, often in conjunction with other tests that monitor clotting factors.
60,000 đ
A blood smear is a sample spread on a glass slide and treated with a special stain. Previously, all blood smears were examined under a microscope by laboratory professionals. Now automated digital systems can help examine blood smears. A blood smear helps diagnose and monitor conditions such as blood disorders, sudden kidney failure, and certain cancer treatments.
44,000 đ
This test helps monitor certain cancers during and after treatment and checks for recurrence. It can identify early signs of ovarian cancer in high-risk patients. Some non-cancerous conditions can increase the level of this protein, such as menstruation and uterine fibroids. Certain cancers may also cause an increased level of CA 125, including ovarian, endometrial, peritoneal, and fallopian tube cancers.
198,000 đ
If your CA 15-3 results are elevated, additional testing is needed to diagnose breast cancer. If the elevation is minimal, you may need to watch, wait, and order a repeat test 4-6 weeks later. The CA 15-3 elevations in non-cancerous conditions tend to be stable over time. If elevation persists or increases, you may need additional testing, such as breast ultrasound, mammography, or a CT scan
198,000 đ
The CA 19.9 quantitative test screens for abnormalities related to the pancreas and bile.
198,000 đ
Cancer antigen CA72-4 is a tumor marker found elevated in various human malignant tumors, including ovarian, gastrointestinal (i.e., stomach, colon, and small bowel), and pancreatic cancer. It is used to manage metastatic and recurrent cancer and assess antitumor therapy response.
198,000 đ
Carcinoembryonic antigen (CEA) is a protein of the developing fetus. CEA levels gradually decrease or disappear after birth. In adults, abnormal CEA levels can indicate cancer. Smoking can also increase CEA. The test helps monitor treatment and checks for the recurrence of cancers of the colon, thyroid gland, rectum, lung, breast, liver, pancreas, stomach, and ovaries.
198,000 đ
A complete blood count is a screening test for various disease states including anemia, leukemia, and inflammatory processes. This test is analyzed based on blood from the cord.
92,000 đ
A complete blood count is a common blood test that is often part of a routine checkup. This test can help detect a variety of disorders, including infections, anemia, immune system disease, and blood cancers.
77,000 đ
A complete blood count is a common blood test in routine checkups. This test can help detect various disorders, including infections and anemia. A reticulocyte count measures the number of immature red blood cells (reticulocytes) in your bone marrow to find out if you are producing enough red blood cells.
110,000 đ
CYFRA 21-1 is useful as a tumor marker, especially for non-small cell lung cancer (NSCLC), CEA, SCC, and other epithelial tumors such as in bladder cancer. This elevation in tumors may be due to cell lysis releasing cell contents into the blood.
198,000 đ
The direct Coombs test detects antibodies stuck to the surface of red blood cells. Many diseases and drugs can cause this to happen. These antibodies sometimes destroy red blood cells, causing anemia. Your healthcare provider may recommend this test if you have signs or symptoms of anemia or jaundice (yellowing of the skin or eyes).
119,000 đ
